Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 8

Results: 6
    1
    2

    The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O.

    Published in:
    Clinical Drug Investigation, 2024, v. 44, n. 8, p. 577, doi. 10.1007/s40261-024-01381-z
    By:
    • Dell'Anno, Irene;
    • Dondi, Leonardo;
    • Esposito, Immacolata;
    • Mascolo, Annamaria;
    • Capuano, Annalisa;
    • de Marchi, Giulia;
    • Cristinziano, Adriano;
    • Tarantino, Domenico;
    • Pani, Marcello;
    • Masini, Carla;
    • Donati, Caterina;
    • Rossin, Elisabetta;
    • Serafini, Antonio;
    • Bagaglini, Gabriele;
    • Bonanni, Gabriella;
    • Gregori, Tommaso;
    • Cavaliere, Arturo;
    • Matocci, Roberta;
    • D'Arpino, Alessandro;
    • Martini, Nello
    Publication type:
    Article
    3
    4

    Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.

    Published in:
    Clinical Drug Investigation, 2024, v. 44, n. 8, p. 553, doi. 10.1007/s40261-024-01379-7
    By:
    • Arriola, Edurne;
    • de Castro, Javier;
    • García-Campelo, Rosario;
    • Bernárdez, Beatriz;
    • Bernabé, Reyes;
    • Bruna, Jordi;
    • Dómine, Manuel;
    • Isla, Dolores;
    • Juan-Vidal, Óscar;
    • López-Fernández, Teresa;
    • Nadal, Ernest;
    • Rodríguez-Abreu, Delvys;
    • Vares, María;
    • Asensio, Úrsula;
    • García, Luis F.;
    • Felip, Enriqueta
    Publication type:
    Article
    5
    6